IHS Chemical Week

People & Business :: Companies

Evonik Industries Buys Tessenderlo's Glycine Business

2:47 AM MDT | July 14, 2010 | Natasha Alperowicz

Evonik Industries says it has acquired the customer list for the pharmaceutical amino acid glycine from Tessenderlo Group (Brussels). Tessenderlo, which is currently undergoing a major portflio shuffle, announced last year that it would exit the glycine market by end of 2010 and will close the Tessenderlo based plant, because of "structural problems in the European market and competition from China." Evonik also has the option to acquire Tessenderlo's specialized glycine production equipment. Evonik makes the amino acid under strict cGMP specifications...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa